MARKET

ADAPY

ADAPY

Adaptimmune Therapeutics Plc
EXMKT
0.027
+0.001
+2.27%
Closed 15:59 01/15 EST
OPEN
0.027
PREV CLOSE
0.026
HIGH
0.027
LOW
0.025
VOLUME
849.42K
TURNOVER
21.79K
52 WEEK HIGH
0.649
52 WEEK LOW
0.020
MARKET CAP
7.16M
P/E (TTM)
-0.0410
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ADAPY last week (0105-0109)?
Weekly Report · 3d ago
Weekly Report: what happened at ADAPY last week (1229-0102)?
Weekly Report · 01/05 09:37
Weekly Report: what happened at ADAPY last week (1222-1226)?
Weekly Report · 12/29/2025 09:36
Weekly Report: what happened at ADAPY last week (1215-1219)?
Weekly Report · 12/22/2025 09:36
Weekly Report: what happened at ADAPY last week (1208-1212)?
Weekly Report · 12/15/2025 09:39
Weekly Report: what happened at ADAPY last week (1201-1205)?
Weekly Report · 12/08/2025 09:39
Weekly Report: what happened at ADAPY last week (1124-1128)?
Weekly Report · 12/01/2025 09:36
Weekly Report: what happened at ADAPY last week (1117-1121)?
Weekly Report · 11/24/2025 09:39
More
About ADAPY
Adaptimmune Therapeutics PLC is focused on pre-clinical programs, including PRAME and CD70-directed T-cell therapies, and its allogeneic pipeline. PRAME is highly expressed across a range of solid tumors, including ovarian, endometrial, lung and breast cancers. The CD70 program targets the CD70 antigen, which is expressed across a range of hematological malignancies (acute myeloid leukemia and lymphoma) and solid tumors (renal cell carcinoma). It is using TRuC technology to develop a T-cell therapy (ADP-520) against CD70, with membrane bound IL-15 to enhance persistence. ADP-520 is in pre-clinical testing. TRuC technology combines the targeting of CAR-T cells with T-cell TCR signaling.

Webull offers Adaptimmune Therapeutics PLC - ADR stock information, including EXMKT: ADAPY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ADAPY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ADAPY stock methods without spending real money on the virtual paper trading platform.